array(3) { ["company_details"]=> array(13) { ["name"]=> string(24) "Idexx Laboratories, Inc." ["slug"]=> string(31) "52dfe-us-idexx-laboratories-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/adce9a3c-023b-4043-9c56-fbed7dab6f62" ["description"]=> string(1658) "10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better.  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries. Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk. Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities." ["address_street"]=> string(10) "1 Idexx Dr" ["address_place"]=> string(9) "Westbrook" ["address_region"]=> string(5) "Maine" ["founding_date"]=> string(10) "1983-02-28" ["website_domain"]=> string(9) "idexx.com" ["website_url"]=> string(21) "https://www.idexx.com" ["industry_codes"]=> array(4) { [0]=> string(43) "General Livestock, Except Dairy and Poultry" [1]=> string(33) "Veterinary Services for Livestock" [2]=> string(27) "Pharmaceutical Preparations" [3]=> string(42) "In Vitro and In Vivo Diagnostic Substances" } ["employee_count"]=> int(710) ["article_count"]=> int(643) } ["articles"]=> array(6) { [0]=> array(7) { ["title_en"]=> string(69) "IBD Rating Upgrades: IDEXX Laboratories Shows Improved Price Strength" ["snippet_en"]=> string(114) "A Relative Strength Rating upgrade for IDEXX Laboratories shows improving technical performance. Will it continue?" ["url"]=> string(112) "https://www.investors.com/ibd-data-stories/ibd-rating-upgrades-idexx-laboratories-shows-improved-price-strength/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/a302aa12-ab58-4362-8b74-4d7c045349b6" ["source"]=> string(13) "investors.com" ["publication_date"]=> string(10) "2024-01-26" ["categories"]=> array(3) { [0]=> string(19) "Economic Conditions" [1]=> string(13) "Credit Rating" [2]=> string(24) "Stock Research & Ratings" } } [1]=> array(7) { ["title_en"]=> string(55) "IDEXX Laboratories Stock Earns IBD Stock Rating Upgrade" ["snippet_en"]=> string(124) "On Wednesday, IDEXX Laboratories now stock clears the 80-plus Relative Strength Rating threshold, with a jump from 79 to 83." ["url"]=> string(87) "https://www.investors.com/news/idexx-laboratories-stock-earns-ibd-stock-rating-upgrade/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/f1554980-231c-484d-9fde-e17dc6859c78" ["source"]=> string(13) "investors.com" ["publication_date"]=> string(10) "2023-12-06" ["categories"]=> array(4) { [0]=> string(12) "Stock Market" [1]=> string(13) "Credit Rating" [2]=> string(24) "Systemic Risk Management" [3]=> string(24) "Stock Research & Ratings" } } [2]=> array(7) { ["title_en"]=> string(86) "Unpacking the Financial Strength and Growth Potential of IDEXX Laboratories Inc (IDXX)" ["snippet_en"]=> string(99) "Insights into the robust financial metrics and competitive advantages driving market outperformance" ["url"]=> string(94) "https://hk.finance.yahoo.com/news/unpacking-financial-strength-growth-potential-160640512.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/a1782171-0f31-4430-839b-79ab5bf16c9a" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-08-29" ["categories"]=> array(1) { [0]=> string(13) "Credit Rating" } } [3]=> array(7) { ["title_en"]=> string(106) "IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Average Recommendation of “Moderate Buy” from Analysts" ["snippet_en"]=> string(306) "Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Rating) have earned a consensus rating of “Moderate Buy” from the ten research firms that are currently covering the company, Marketbeat reports. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company." ["url"]=> string(140) "https://www.defenseworld.net/2023/02/18/idexx-laboratories-inc-nasdaqidxx-receives-average-recommendation-of-moderate-buy-from-analysts.html" ["image_url"]=> NULL ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2023-02-18" ["categories"]=> array(2) { [0]=> string(12) "Stock Market" [1]=> string(13) "Credit Rating" } } [4]=> array(7) { ["title_en"]=> string(95) "Morgan Stanley Maintains Overweight Rating for IDEXX Laboratories: Here's What You Need To Know" ["snippet_en"]=> string(149) "Morgan Stanley has decided to maintain its Overweight rating of IDEXX Laboratories (NASDAQ:IDXX) and lower its price target from $573.00 to $543.0..." ["url"]=> string(153) "https://markets.businessinsider.com/news/stocks/morgan-stanley-maintains-overweight-rating-for-idexx-laboratories-here-s-what-you-need-to-know-1031916010" ["image_url"]=> NULL ["source"]=> string(19) "businessinsider.com" ["publication_date"]=> string(10) "2022-11-15" ["categories"]=> array(2) { [0]=> string(12) "Stock Market" [1]=> string(13) "Credit Rating" } } [5]=> array(7) { ["title_en"]=> string(82) "Idexx Laboratories Sees Composite Rating Improve To 98 | Investor's Business Daily" ["snippet_en"]=> string(101) "On Friday, Idexx Laboratories got an upgrade for its IBD SmartSelect Composite Rating from 93 to 98." ["url"]=> string(98) "https://www.investors.com/ibd-data-stories/idexx-laboratories-sees-composite-rating-improve-to-98/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/e2330cbc-6ebc-4393-a7f6-ed8edd43002d" ["source"]=> string(13) "investors.com" ["publication_date"]=> string(10) "2020-10-30" ["categories"]=> array(1) { [0]=> string(13) "Credit Rating" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(117) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(67) } [2]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(44) } [3]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(43) } [4]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(40) } [5]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(24) } [6]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(22) } [7]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(22) } [8]=> array(2) { ["name"]=> string(12) "Restatements" ["count"]=> int(21) } [9]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(19) } [10]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(18) } [11]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(16) } [12]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(14) } [13]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(12) } [14]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(9) } [15]=> array(2) { ["name"]=> string(9) "Investors" ["count"]=> int(9) } [16]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(8) } [17]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(8) } [18]=> array(2) { ["name"]=> string(31) "Water and Wastewater Management" ["count"]=> int(7) } [19]=> array(2) { ["name"]=> string(16) "Share Repurchase" ["count"]=> int(7) } [20]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(7) } [21]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(7) } [22]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(7) } [23]=> array(2) { ["name"]=> string(13) "Credit Rating" ["count"]=> int(6) } [24]=> array(2) { ["name"]=> string(10) "New Market" ["count"]=> int(6) } [25]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(6) } [26]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(5) } [27]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(5) } [28]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(5) } [29]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(5) } } } 52dfe-us-idexx-laboratories-inc

Idexx Laboratories, Inc.

Location

Maine

Founded

1983-02-28

Website

https://www.idexx.com

Articles

643 Articles

Category

General Livestock, Except Dairy and Poultry

Veterinary Services for Livestock

Pharmaceutical Preparations

In Vitro and In Vivo Diagnostic Substances

Description

10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better.  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries. Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk. Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities.

Articles

IBD Rating Upgrades: IDEXX Laboratories Shows Improved Price Strength

2024-01-26 (investors.com)

IBD Rating Upgrades: IDEXX Laboratories Shows Improved Price Strength

A Relative Strength Rating upgrade for IDEXX Laboratories shows improving technical performance. Will it continue?

Read more
IDEXX Laboratories Stock Earns IBD Stock Rating Upgrade

2023-12-06 (investors.com)

IDEXX Laboratories Stock Earns IBD Stock Rating Upgrade

On Wednesday, IDEXX Laboratories now stock clears the 80-plus Relative Strength Rating threshold, with a jump from 79 to 83.

Read more
Unpacking the Financial Strength and Growth Potential of IDEXX Laboratories Inc (IDXX)

2023-08-29 (yahoo.com)

Unpacking the Financial Strength and Growth Potential of IDEXX Laboratories Inc (IDXX)

Insights into the robust financial metrics and competitive advantages driving market outperformance

Read more
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Average Recommendation of “Moderate Buy” from Analysts

2023-02-18 (defenseworld.net)

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Rating) have earned a consensus rating of “Moderate Buy” from the ten research firms that are currently covering the company, Marketbeat reports. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company.

Read more
Morgan Stanley Maintains Overweight Rating for IDEXX Laboratories: Here's What You Need To Know

2022-11-15 (businessinsider.com)

Morgan Stanley Maintains Overweight Rating for IDEXX Laboratories: Here's What You Need To Know

Morgan Stanley has decided to maintain its Overweight rating of IDEXX Laboratories (NASDAQ:IDXX) and lower its price target from $573.00 to $543.0...

Read more
Idexx Laboratories Sees Composite Rating Improve To 98 | Investor's Business Daily

2020-10-30 (investors.com)

Idexx Laboratories Sees Composite Rating Improve To 98 | Investor's Business Daily

On Friday, Idexx Laboratories got an upgrade for its IBD SmartSelect Composite Rating from 93 to 98.

Read more

Newsletter subscription